Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis.

NCT04077905 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Hemophagocytic Lymphohistiocytosis

Interventions

DRUG: Pegylated liposomal doxorubicin
DRUG: Etoposide
DRUG: Methylprednisolone

Sponsor

Beijing Friendship Hospital